Posted on
Republicans Disrupt Hearing on Pharma Tax Rates With OECD Gripes
Republican senators derailed a May 11 hearing meant to address American pharmaceutical companies’ low effective tax rates with complaints about U.S. participation in OECD pillar 2 international tax talks.